heparan sulfate synthesis inhibitors (Dorphan)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameheparan sulfate synthesis inhibitors (Dorphan)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMucopolysaccharidoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDorphan SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDorphan SA
Active IndicationsN/A
Inactive IndicationsMucopolysaccharidoses

Other Information

ATC CodeN/A
Related LinksN/A